(Q27088179)
Statements
505.102±0 dalton
1 reference
GSK2126458 (English)
19 October 2016
C₂₅H₁₇F₂N₅O₃S
1 reference
GSK2126458 (English)
19 October 2016
COC1=C(C=C(C=N1)C2=CC3=C(C=CN=C3C=C2)C4=CN=NC=C4)NS(=O)(=O)C5=C(C=C(C=C5)F)F
1 reference
GSK2126458 (English)
19 October 2016
1 reference
1 reference
Identifiers
2 references
GSK2126458 (English)
19 October 2016
2 references
omipalisib (English)
19 October 2016
1 reference
Omipalisib (English)
19 October 2016
2 references
GSK2126458 (English)
19 October 2016
2 references
1 reference
OMIPALISIB (English)
19 October 2016
629-873-1
1 reference
27 December 2018
2,4-difluoro-N-{2-methoxy-5-[4-(pyridazin-4-yl)quinolin-6-yl]pyridin-3-yl}benzene-1-sulfonamide (English)
CAS no.: 1086062-66-9 (English)
1 reference
27 December 2018
2,4-difluoro-N-{2-methoxy-5-[4-(pyridazin-4-yl)quinolin-6-yl]pyridin-3-yl}benzene-1-sulfonamide (English)
CAS no.: 1086062-66-9 (English)
1 reference
omipalisib (English)
19 October 2016
2 references
omipalisib (English)
19 October 2016
1 reference
3L08 (English)
19 October 2016